NCT01139346View on ClinicalTrials.gov

Study of Oral Darinaparsin in Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

April 30, 2012

Study Completion Date

April 30, 2012

Conditions
Advanced Solid Tumors
Interventions
DRUG

darinaparsin

dose escalating, starting at 200 mg twice per day for 21 days continuous followed by a 7 day rest per cycle.

Trial Locations (3)

47905

Lafayette

Unknown

Dallas

Houston

Sponsors
All Listed Sponsors
lead

Alaunos Therapeutics

INDUSTRY